AXGN:NASDAQ
AxoGen, Inc Common Stock
$39.56
arrow_upward
+0.22%(+0.085) 1D
Hun 1, 9:54:13 AM GMT-4 · USD
search
Lahat ng simbolo
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa AXGN...
Buksan
$38.66
Mataas
$40.28
Mababa
$38.66
Mkt. cap
2.14B
Avg. na dami
1.04M
Dami
41.08K
Mataas nang 52-wk
$45.83
Mababa nang 52-wk
$9.22
EPS
-$0.64
Beta
1.17
Mga natitirang share
53.18M
Bilang ng mga empleyado
622
Buksan
$38.66
Mataas
$40.28
Mababa
$38.66
Mkt. cap
2.14B
Avg. na dami
1.04M
Dami
41.08K
Mataas nang 52-wk
$45.83
Mababa nang 52-wk
$9.22
EPS
-$0.64
Beta
1.17
Mga natitirang share
53.18M
Bilang ng mga empleyado
622
Mga balita at kwento
Mula sa mga source sa buong web
Nagka-error
Profile
Axogen is a developer of surgical solutions, including human tissue grafts, based in Alachua, Florida. Axogen products are designed to remedy peripheral nerve damage. In 2013 the company raised $18 million in its initial public offering. Axogen uses a cell graft technology AVANCE to mimic a human nerve. The company also creates nerve connectors and soft tissue membranes. The company reports sensory and movement recovery in 87 percent of patients with peripheral nerve injuries. Axogen is part of the Sid Martin Biotechnology Incubator.
As of 2019, Axogen was the only commercially available allograft approved by the Food and Drug Administration for clinical use. Wikipedia
Tungkol sa AxoGen, Inc Common Stock
CEO-
Mga Empleyado622
Itinatag2002
HeadquartersAlachua, Florida, Estados Unidos
Sektor-
Websiteaxogeninc.com
Posibleng magkaroon ng mga pagkakamali ang AI content. Matuto pa